Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Pazopanib in Patients with Cle...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right Patient

Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right Patient

Bibliographic Details
Main Authors: Camillo Porta, Alessandra Ferrari, Anna M. Czarnecka, Cezary A. Szczylik
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-06-01
Series:Frontiers in Pharmacology
Subjects:
angiogenesis inhibitor
clear cell renal carcinoma
pazopanib
real-world
poor risk
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2017.00329/full
  • Holdings
  • Description
  • Similar Items
  • Staff View
Description
ISSN:1663-9812

Similar Items

  • Pazopanib in the management of advanced soft tissue sarcomas
    by: Cranmer LD, et al.
    Published: (2016-06-01)
  • Pazopanib for treating rhabdomyosarcoma in adult patients with poor performance status: A case report
    by: Yuuya Nishii, et al.
    Published: (2022-11-01)
  • Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma
    by: Sabrina Rossetti, et al.
    Published: (2017-07-01)
  • Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors
    by: Sylvie Négrier, et al.
    Published: (2017-08-01)
  • Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study
    by: Erman Mustafa, et al.
    Published: (2021-09-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs